(Q40552298)

21 September 2017

Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis (English)

1 reference

21 September 2017

0 references

1 reference

Saccharomyces boulardii

object named as

saccharomyces boulardii

1 reference

inferred from title

author name string

Fariborz Mansour-Ghanaei

1

1 reference

21 September 2017

Najaf Dehbashi

2

1 reference

21 September 2017

Kamyar Yazdanparast

3

1 reference

21 September 2017

Afshin Shafaghi

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

World Journal of Gastroenterology

21 September 2017

1 reference

21 September 2017

9

1 reference

21 September 2017

8

1 reference

21 September 2017

1832-1833

1 reference

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

21 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

Amoebic colitis: Review of 295 cases

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611554

Pathogenesis of amoebiasis

20 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V9.I8.1832

Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea--a pilot study

21 January 2018

1 reference

12 December 2020

Mycoserological study of the treatment of paediatric cystic fibrosis patients with Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926)

1 reference

12 December 2020

Probiotics and infectious diarrhea

1 reference

12 December 2020

Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum

1 reference

12 December 2020

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

12 December 2020

Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects

1 reference

12 December 2020

Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii

1 reference

12 December 2020

Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V9.I8.1832

1 reference

21 September 2017

1 reference

21 September 2017

PubMed publication ID

12918131

1 reference